COLL

NASDAQ 已收盘

Collegium Pharmaceutical, Inc.

35.73 USD
+0.19+0.42%
盘后 34.00 -4.44%
2026-08-03
市值
$1.16B
市盈率
21.79
EPS
1.64
股息率
52 周区间
29.70 – 50.79
成交量
438.60K
Beta
0.73
目标价
53.60
52W 低 29.7052W 高 50.79
价格走势

公司简介

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company’s portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxyco...